Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma
Open Access
- 1 February 2019
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 8 (1) , 17-22
Abstract
Background: This study aimed to investigate whether the pretreatment platelet to lymphocyte ratio (PLR) is a significant prognostic factor in metastatic pancreatic ductal adenocarcinoma (PDAC). Methods: A total of 134 histologically confirmed PDAC patients were included in our retrospective study. The data included treatment regimens, Karnofsky Performance Status (KPS), and PLR. Kaplan-Meier curves and univariate and multivariate Cox proportional hazards regression analyses were applied to identify the prognostic factors associated with overall survival (OS). Results: We used the receiver operating characteristic (ROC) curve to set the cut-off value of the PLR. For the Kaplan-Meier analysis, the median overall survival in PDAC patients with a PLR of 123 or less was 19.7 months, whereas the values in those with a PLR greater than 123 was 13.7 months (P=0.014). PLR was a significant prognostic marker in the multivariate Cox model [hazard ratio (HR) =1.721, 95% CI: 1.162–2.550, P=0.007]. Conclusions: The PLR pretreatment had potential as prognostic indicator in patients with metastatic PDAC.Keywords
This publication has 29 references indexed in Scilit:
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- Tumor–platelet interaction in solid tumorsInternational Journal of Cancer, 2012
- Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancerBiomarkers, 2012
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioThe American Journal of Surgery, 2010
- Immunity, Inflammation, and CancerCell, 2010
- The Immune Response to TumorsCurrent Protocols in Immunology, 2009
- Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinomaHPB, 2007
- Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escapeCytokine & Growth Factor Reviews, 2007
- Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreasThe American Journal of Surgery, 2005
- Cytokines in pancreatic carcinomaCancer, 2004